Education
About Us
Working with TipRanks
Follow Us
BB Biotech AG (GB:0JYO)
LSE:0JYO
0JYO Stock Chart & Stats
Day’s Range― - ―
52-Week RangeCHF24.50 - CHF43.95
Previous CloseN/A
Volume269.00
Average Volume (3M)1.65K
Market Cap
CHF1.76B
Enterprise ValueCHF3.79B
Total Cash (Recent Filing)CHF2.41B
Total Debt (Recent Filing)CHF117.50M
Price to Earnings (P/E)20.4
Beta1.34
Next Earnings
Oct 24, 2025EPS EstimateN/A
Last Dividend Ex-Date
Mar 21, 2025Dividend Yield5.51%
Share Statistics
EPS (TTM)N/A
Shares Outstanding55,400,000
10 Day Avg. Volume1,623
30 Day Avg. Volume1,650
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)1.08
Price to Sales (P/S)0.00
P/FCF Ratio17.07
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
CHF66.00Price Target Upside105.93% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
BB Biotech News
PremiumCompany Announcements
BB Biotech Outperforms Nasdaq Biotech Index in Q2 2025
PremiumCompany Announcements
BB Biotech AG Reports Significant Loss in H1 2025
PremiumCompany Announcements
BB Biotech AG Announces Change in Shareholdings
PremiumCompany Announcements
BB Biotech AG Reports Q1 2025 Loss Amidst Market Challenges
PremiumCompany Announcements
BB Biotech Refines Portfolio Amid Market Challenges in Q1 2025
PremiumCompany Announcements
BB Biotech AG Approves Dividend and Re-elects Board MembersOptions Prices
Currently, No data available
---
Ownership Overview
― Insiders
<0.01%
Mutual Funds
― Other Institutional Investors
99.37% Public Companies and
Individual Investors
0JYO FAQ
What was BB Biotech AG’s price range in the past 12 months?
BB Biotech AG lowest share price was CHF24.50 and its highest was CHF43.95 in the past 12 months.
What is BB Biotech AG’s market cap?
BB Biotech AG’s market cap is CHF1.76B.
When is BB Biotech AG’s upcoming earnings report date?
BB Biotech AG’s upcoming earnings report date is Oct 24, 2025 which is in 90 days.
How were BB Biotech AG’s earnings last quarter?
Currently, no data Available
Is BB Biotech AG overvalued?
According to Wall Street analysts BB Biotech AG’s price is currently Undervalued.
Does BB Biotech AG pay dividends?
BB Biotech AG pays a Annually dividend of CHF1.799 which represents an annual dividend yield of 5.51%. See more information on BB Biotech AG dividends here
What is BB Biotech AG’s EPS estimate?
BB Biotech AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BB Biotech AG have?
BB Biotech AG has 55,400,000 shares outstanding.
What happened to BB Biotech AG’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of BB Biotech AG?
Currently, no hedge funds are holding shares in GB:0JYO
Company Description
BB Biotech AG
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.
Technical Analysis
Basilea Pharmaceutica
―
Idorsia Ltd
―
Kuros Biosciences
―
Newron Pharmaceuticals SpA
―
Santhera Pharmaceuticals Holding
―